摘要
第一次全国经济普查数据显示,2004年云南医药产业结构正向着协调化、高度化方向调整。非公有制经济过半,国有企业比重显著下降;在云南高技术产业出口额中,医药制造业跃居第二位;云南医药制造业的研发(R&D)投入强度1.2%,高出全省0.76个百分点;医药产业的专利申请数和拥有专利数不仅在云南7个高技术产业中占据首位,而且在全省全部工业中也占据首位;医药制造业成为云南高技术产业的主干行业,位居第五大行业;医药工业已进入云南十大工业之列;“三点一带”的云南医药产业空间格局凸现。同时云南医药产业尚存在产品的市场占有率低、第一产业薄弱、集中度偏低、增幅缓慢、亏损面大等问题。为此,应尽快研究和制定云药产业结构的调整规划、产品指导目录、空间政策以及医疗服务的配套政策,促进产业结构优化。
The medicine sector structure in Yurman has been greatly improved while there still exist such problems as low market shares, weakness of first industry, low intensiveness, small growth and loss of many enterprises. In order to improve that mentioned above, it is entitled to study and formulate an adjustment plan for the structure of Yunnan medicine industry, which in addition, should include at least a guiding catalog of products and coordinating policy on medical services.
出处
《学术探索》
2007年第2期50-59,共10页
Academic Exploration
基金
云南省人民政府第一次全国经济普查课题<云南医药产业的现状及发展对策>(编号:2006-YN-JP-18)的部分成果
